Bio Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Bio Techne Corp
TECH Stock  USD 63.79  0.00  0.00%   
Bio Techne's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Bio Techne's valuation are provided below:
Gross Profit
813.2 M
Profit Margin
0.0641
Market Capitalization
10 B
Enterprise Value Revenue
8.4123
Revenue
1.2 B
We have found one hundred twenty available fundamental signals for Bio Techne Corp, which can be analyzed and compared to other ratios and to its rivals. Traders should compare all of Bio Techne Corp prevailing fundamentals against the fundamentals between 2010 and 2026 to make sure the company is sustainable this year. The Bio Techne's current Market Cap is estimated to increase to about 2.4 B. The Bio Techne's current Enterprise Value is estimated to increase to about 2.3 B

Bio Techne Total Revenue

1.47 Billion

Check Bio Techne financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio Techne's main balance sheet or income statement drivers, such as Depreciation And Amortization of 132.7 M, Total Revenue of 1.5 B or Gross Profit of 954.3 M, as well as many indicators such as Price To Sales Ratio of 6.86, Dividend Yield of 0.0106 or PTB Ratio of 6.72. Bio financial statements analysis is a perfect complement when working with Bio Techne Valuation or Volatility modules.
  
Build AI portfolio with Bio Stock
Check out the analysis of Bio Techne Correlation against competitors.

Bio Techne Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3.1 B2.9 B1.8 B
Slightly volatile
Short and Long Term Debt Total536.2 M510.7 M296.3 M
Slightly volatile
Total Current Liabilities212.3 M202.2 M107 M
Slightly volatile
Total Stockholder Equity2.3 B2.2 B1.3 B
Slightly volatile
Property Plant And Equipment Net385.3 M367 M210.2 M
Slightly volatile
Retained Earnings1.3 B1.2 B902 M
Slightly volatile
Cash195.8 M186.5 M142.9 M
Slightly volatile
Non Current Assets Total2.4 B2.2 B1.3 B
Slightly volatile
Cash And Short Term Investments138.3 M186.5 M192.5 M
Very volatile
Net Receivables249.8 M237.9 M134.7 M
Slightly volatile
Common Stock Shares Outstanding169.4 M183.7 M155.6 M
Slightly volatile
Liabilities And Stockholders Equity3.1 B2.9 B1.8 B
Slightly volatile
Non Current Liabilities Total559.3 M532.7 M354.5 M
Slightly volatile
Inventory228.8 M217.9 M106.2 M
Slightly volatile
Other Current Assets60.1 M57.3 M22.6 M
Slightly volatile
Other Stockholder Equity1.1 B1 B454.6 M
Slightly volatile
Total Liabilities771.7 M734.9 M461.5 M
Slightly volatile
Total Current Assets734.5 M699.5 M459.3 M
Slightly volatile
Short Term Debt17 M16.2 M11.5 M
Slightly volatile
Accounts Payable30.6 M29.1 M22.9 M
Slightly volatile
Intangible Assets441.5 M420.4 M365.4 M
Slightly volatile
Property Plant And Equipment Gross730.8 M696 M282.1 M
Slightly volatile
Common Stock Total Equity1.9 M1.8 M752.3 K
Slightly volatile
Common Stock1.9 M1.8 M816.5 K
Slightly volatile
Other Liabilities97.2 M114.9 M90.4 M
Slightly volatile
Property Plant Equipment139.9 M260.1 M174.1 M
Slightly volatile
Good Will1.2 B1.1 B623.4 M
Slightly volatile
Capital Surpluse871.3 M829.8 M419.6 M
Slightly volatile
Short and Long Term Debt13.7 M14.4 M30.6 M
Very volatile
Non Current Liabilities Other20.4 M31.1 M18.7 M
Slightly volatile
Long Term Debt Total318.6 M402.5 M254.1 M
Slightly volatile
Net Invested Capital1.4 B2.6 B1.4 B
Pretty Stable
Net Working Capital418.9 M497.3 M330.5 M
Slightly volatile
Capital Stock982.8 K1.8 M708.9 K
Slightly volatile
Capital Lease Obligations97.1 M112.8 M84.1 M
Slightly volatile

Bio Techne Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization132.7 M126.4 M69.8 M
Slightly volatile
Total Revenue1.5 B1.4 B766.6 M
Slightly volatile
Gross Profit954.3 M908.8 M512.6 M
Slightly volatile
Other Operating Expenses1.3 B1.3 B606.4 M
Slightly volatile
Operating Income113.1 M117.6 M158.6 M
Slightly volatile
EBIT117.6 M123 M167.2 M
Slightly volatile
EBITDA148.7 M249.4 M231 M
Slightly volatile
Cost Of Revenue518.5 M493.8 M254 M
Slightly volatile
Total Operating Expenses830.8 M791.2 M352.4 M
Slightly volatile
Income Before Tax114.2 M113.2 M159.6 M
Pretty Stable
Net Income87.1 M84.4 M128.7 M
Slightly volatile
Income Tax Expense27.4 M28.8 M31.6 M
Pretty Stable
Research Development120.1 M114.4 M64.6 M
Slightly volatile
Selling General Administrative501.2 M477.4 M238.7 M
Slightly volatile
Net Income Applicable To Common Shares344.5 M328.1 M179 M
Slightly volatile
Net Income From Continuing Ops155.3 M84.4 M138.7 M
Slightly volatile
Interest Income1.8 M3.5 M3.6 M
Slightly volatile
Selling And Marketing Expenses40.4 M80 M44.1 M
Pretty Stable
Reconciled Depreciation98.2 M126.4 M81.6 M
Slightly volatile
Extraordinary Items26.6 M29.9 M32.6 M
Slightly volatile

Bio Techne Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow309.8 M295 M181.2 M
Slightly volatile
Begin Period Cash Flow89.3 M174.6 M130.9 M
Slightly volatile
Depreciation132.7 M126.4 M69.8 M
Slightly volatile
Capital Expenditures18.3 M35.7 M27.5 M
Slightly volatile
Total Cash From Operating Activities347.2 M330.7 M209.9 M
Slightly volatile
Net Income89.2 M84.4 M128.2 M
Slightly volatile
End Period Cash Flow94.2 M186.5 M136.8 M
Pretty Stable
Stock Based Compensation49.3 M47 M25.7 M
Slightly volatile
Dividends Paid50.1 M57.9 M47.3 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio6.865.989.2075
Pretty Stable
Dividend Yield0.01060.00720.0088
Slightly volatile
PTB Ratio6.724.865.5903
Slightly volatile
Days Sales Outstanding46.0655.7261.7622
Very volatile
Book Value Per Share11.5110.968.1285
Slightly volatile
Free Cash Flow Yield0.03210.03640.0283
Slightly volatile
Operating Cash Flow Per Share1.731.641.308
Slightly volatile
Average Payables3.9 M3.8 M3.4 M
Pretty Stable
Stock Based Compensation To Revenue0.01970.03010.027
Slightly volatile
Capex To Depreciation0.310.320.5646
Slightly volatile
PB Ratio6.724.865.5903
Slightly volatile
EV To Sales6.786.199.2929
Slightly volatile
Free Cash Flow Per Share1.541.471.1282
Slightly volatile
ROIC0.03480.03660.0892
Slightly volatile
Inventory Turnover4.292.612.6979
Very volatile
Net Income Per Share0.420.4660.825
Pretty Stable
Days Of Inventory On Hand86.64145141
Very volatile
Payables Turnover8.5915.2711.8485
Pretty Stable
Sales General And Administrative To Revenue0.180.310.2721
Slightly volatile
Average Inventory4.4 M5.6 M6 M
Pretty Stable
Research And Ddevelopement To Revenue0.120.09380.0931
Slightly volatile
Capex To Revenue0.02780.02920.0387
Very volatile
Cash Per Share0.660.931.2377
Pretty Stable
POCF Ratio23.5725.3732.6527
Slightly volatile
Interest Coverage13.1313.8243.9746
Slightly volatile
Payout Ratio0.650.620.412
Slightly volatile
Capex To Operating Cash Flow0.120.10780.1498
Pretty Stable
PFCF Ratio46.1836.3340.2836
Slightly volatile
Days Payables Outstanding40.4124.7432.0804
Pretty Stable
Income Quality3.73.531.8134
Slightly volatile
ROE0.04180.0440.1106
Slightly volatile
EV To Operating Cash Flow23.3726.2533.1054
Slightly volatile
PE Ratio10499.3759.1579
Slightly volatile
Return On Tangible Assets0.05180.05450.1766
Slightly volatile
EV To Free Cash Flow33.4229.4239.6205
Slightly volatile
Earnings Yield0.00990.01040.0224
Slightly volatile
Intangibles To Total Assets0.50.470.5015
Slightly volatile
Current Ratio3.783.985.7194
Slightly volatile
Receivables Turnover7.156.786.0435
Pretty Stable
Graham Number5.2610.1711.6018
Slightly volatile
Shareholders Equity Per Share11.5110.968.1257
Slightly volatile
Debt To Equity0.140.210.2022
Slightly volatile
Capex Per Share0.190.180.1804
Slightly volatile
Average Receivables16.3 M18.8 M20.4 M
Slightly volatile
Revenue Per Share7.326.974.7324
Slightly volatile
Interest Debt Per Share2.722.591.8827
Slightly volatile
Debt To Assets0.10.160.14
Slightly volatile
Enterprise Value Over EBITDA17.6334.828.3474
Slightly volatile
Short Term Coverage Ratios39.4629.9323.9527
Slightly volatile
Price Earnings Ratio10499.3759.1579
Slightly volatile
Operating Cycle133201203
Pretty Stable
Price Book Value Ratio6.724.865.5903
Slightly volatile
Days Of Payables Outstanding40.4124.7432.0804
Pretty Stable
Dividend Payout Ratio0.650.620.412
Slightly volatile
Price To Operating Cash Flows Ratio23.5725.3732.6527
Slightly volatile
Price To Free Cash Flows Ratio46.1836.3340.2836
Slightly volatile
Pretax Profit Margin0.0690.07270.2476
Slightly volatile
Ebt Per Ebit0.80.870.9864
Pretty Stable
Operating Profit Margin0.07170.07550.2454
Slightly volatile
Company Equity Multiplier1.391.531.3888
Very volatile
Long Term Debt To Capitalization0.10.140.1363
Slightly volatile
Total Debt To Capitalization0.120.170.16
Slightly volatile
Return On Capital Employed0.04690.04940.1172
Slightly volatile
Debt Equity Ratio0.140.210.2022
Slightly volatile
Ebit Per Revenue0.07170.07550.2454
Slightly volatile
Quick Ratio2.62.744.6785
Slightly volatile
Dividend Paid And Capex Coverage Ratio4.814.062.8407
Slightly volatile
Net Income Per E B T0.580.670.7714
Pretty Stable
Cash Ratio0.790.832.0766
Slightly volatile
Cash Conversion Cycle104181173
Very volatile
Operating Cash Flow Sales Ratio0.240.210.2789
Pretty Stable
Days Of Inventory Outstanding86.64145141
Very volatile
Days Of Sales Outstanding46.0655.7261.7622
Very volatile
Free Cash Flow Operating Cash Flow Ratio0.610.80.8296
Pretty Stable
Cash Flow Coverage Ratios0.710.742.5393
Slightly volatile
Price To Book Ratio6.724.865.5903
Slightly volatile
Fixed Asset Turnover5.394.44.6006
Slightly volatile
Capital Expenditure Coverage Ratio6.868.357.9126
Pretty Stable
Price Cash Flow Ratio23.5725.3732.6527
Slightly volatile
Enterprise Value Multiple17.6334.828.3474
Slightly volatile
Debt Ratio0.10.160.14
Slightly volatile
Cash Flow To Debt Ratio0.710.742.5393
Slightly volatile
Price Sales Ratio6.865.989.2075
Pretty Stable
Return On Assets0.03140.0330.0838
Slightly volatile
Asset Turnover0.840.550.5468
Pretty Stable
Net Profit Margin0.05150.05420.1909
Slightly volatile
Gross Profit Margin0.560.580.6594
Slightly volatile
Price Fair Value6.724.865.5903
Slightly volatile
Return On Equity0.04180.0440.1106
Slightly volatile

Bio Techne Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap2.4 B2.3 B2.4 B
Slightly volatile
Enterprise Value2.3 B2.2 B2.2 B
Slightly volatile

Bio Fundamental Market Drivers

Forward Price Earnings32.1543
Cash And Short Term Investments162.2 M

Bio Upcoming Events

1st of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
13th of August 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
30th of June 2023
Last Financial Announcement
View

About Bio Techne Financial Statements

Investors use fundamental indicators, such as Bio Techne's revenue or net income, to determine how well the company is positioned to perform in the future. Although Bio Techne's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue37.5 M39.3 M
Total Revenue1.4 B1.5 B
Cost Of Revenue493.8 M518.5 M
Stock Based Compensation To Revenue 0.03  0.02 
Sales General And Administrative To Revenue 0.31  0.18 
Research And Ddevelopement To Revenue 0.09  0.12 
Capex To Revenue 0.03  0.03 
Revenue Per Share 6.97  7.32 
Ebit Per Revenue 0.08  0.07 

Currently Active Assets on Macroaxis

VGIAXVanguard Growth And
XARSPDR SP Aerospace
XARSPDR SP Aerospace
XARSPDR SP Aerospace
ASMLASML Holding NV
When determining whether Bio Techne Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Techne's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Techne Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Techne Corp Stock:
How To Invest In Bio
Details
Is Bio Stock a good investment?
Details
What is Bio Techne's Net Worth?
Details
Largest Life Sciences Tools & Services Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Bio Techne Correlation against competitors.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is there potential for Life Sciences Tools & Services market expansion? Will Bio introduce new products? Factors like these will boost the valuation of Bio Techne. If investors know Bio will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Bio Techne listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.143
Dividend Share
0.32
Earnings Share
0.49
Revenue Per Share
7.762
Quarterly Revenue Growth
(0.01)
Understanding Bio Techne Corp requires distinguishing between market price and book value, where the latter reflects Bio's accounting equity. The concept of intrinsic value—what Bio Techne's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Bio Techne's price substantially above or below its fundamental value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Bio Techne's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Techne is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Bio Techne's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY